4.6 Article

Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data

期刊

AMERICAN JOURNAL OF TRANSPLANTATION
卷 22, 期 12, 页码 2821-2833

出版社

WILEY
DOI: 10.1111/ajt.17192

关键词

biopsy; classification systems: Banff classification; clinical research / practice; kidney transplantation / nephrology; rejection: antibody-mediated (ABMR); rejection: T cell mediated (TCMR)

资金

  1. ERACoSysMed-2, the ERA-Net for Systems Medicine in clinical research and medical practice [JTC2 29]

向作者/读者索取更多资源

In this study, artificial intelligence classifiers were used to interpret kidney graft biopsies and diagnose rejection. The classifiers showed high sensitivity and specificity, and had excellent concordance with the Banff classification rules and expert diagnoses. This research demonstrates the potential of using AI classifiers in improving the interpretation of kidney graft biopsies.
Interpretation of kidney graft biopsies using the Banff classification is still heterogeneous. In this study, extreme gradient boosting classifiers learned from two large training datasets (n = 631 and 304 cases) where the reference diagnoses were not strictly defined following the Banff rules but from central reading by expert pathologists and further interpreted consensually by experienced transplant nephrologists, in light of the clinical context. In three external validation datasets (n = 3744, 589, and 360), the classifiers yielded a mean ROC curve AUC (95% CI) of: 0.97 (0.92-1.00), 0.97 (0.96-0.97), and 0.95 (0.93-0.97) for antibody-mediated rejection (ABMR); 0.94 (0.91-0.96), 0.94 (0.92-0.95), and 0.91 (0.88-0.95) for T cell-mediated rejection; >0.96 (0.90-1.00) with all three for interstitial fibrosis-tubular atrophy. We also developed a classifier to discriminate active and chronic active ABMR with 95% accuracy. In conclusion, we built highly sensitive and specific artificial intelligence classifiers able to interpret kidney graft scoring together with a few clinical data and automatically diagnose rejection, with excellent concordance with the Banff rules and reference diagnoses made by a group of experts. Some discrepancies may point toward possible improvements that could be made to the Banff classification.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Urology & Nephrology

A 39 year-old man with acroparesthesia and uncommon renal arterial lesions. What is the diagnosis?

Antoine Creon, Elsa Ferriere, Marion Rabant, Jean-Paul Duong Van Huyen, Pierre Isnard

JOURNAL OF NEPHROLOGY (2023)

Article Statistics & Probability

A joint transition model for evaluating eGFR as biomarker for rejection after kidney transplantation

Maarten Coemans, Geert Verbeke, Maarten Naesens

Summary: This study examines the diagnostic value of estimated glomerular filtration rate (eGFR) in kidney graft rejection by building a joint model that combines characteristics of transition models and shared parameter models. Applying the model to data from University Hospitals Leuven, the study concludes that a negative deviation from the mean eGFR slope increases the probability of rejection in indication biopsies, but using the eGFR profile alone has limited benefit for diagnosing rejection when considering biopsy history. Methodologically, the study fills a gap in the biomarker literature by relating a frequently measured continuous outcome with a less frequently measured binary indicator, and the developed joint transition model is versatile and applicable to other research settings.

STATISTICAL MODELLING (2023)

Review Immunology

Seeking Standardized Definitions for HLA-incompatible Kidney Transplants: A Systematic Review

Sukhdeep S. Jatana, Hedi Zhao, Laurine M. Bow, Emanuele Cozzi, Ibrahim Batal, Tillie Horak, Alexandre Amar-Zifkin, Carrie Schinstock, Medhat Askar, Darshana M. Dadhania, Matthew Cooper, Maarten Naesens, Edward S. Kraus, Ruth Sapir-Pichhadze

Summary: This study systematically assessed the definition and prognostic implications of HLA incompatibility in transplant outcomes, finding heterogeneity in the definition and incomplete reporting of variables. The risk of bias in studies examining the association between death-censored graft failure and HLA incompatibility was high. Therefore, optimizing HLA compatibility assessment and standardizing the reporting of variables are necessary for improving transplant outcomes and promoting international collaboration.

TRANSPLANTATION (2023)

Article Surgery

Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration

Anna Buxeda, Laura Llinas-Mallol, Javier Gimeno, Dolores Redondo-Pachon, Carlos Arias-Cabrales, Carla Burballa, Adrian Puche, Miguel Lopez-Botet, Jose Yelamos, Carlos Vilches, Maarten Naesens, Maria Jose Perez-Saez, Julio Pascual, Marta Crespo

Summary: Isolated microvascular inflammation (iMVI) is a rare phenotype that cannot be classified as antibody-mediated rejection (ABMR) in recent Banff classifications because it lacks HLA donor-specific antibodies or C4d deposition. In this study, we compared peripheral blood leukocyte distribution and inflammatory infiltrates in kidney transplant biopsies among ABMR, iMVI, and normal cases. We found that iMVI had fewer lymphocytes and peripheral T cells compared to ABMR and normal cases, but more NKG2A+ NK cells. iMVI also showed decreased plasma cell infiltration and increased cytotoxic T cell infiltration compared to ABMR.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Medical Laboratory Technology

Longitudinal Exposure to Tacrolimus and New-Onset Diabetes Mellitus in Renal Transplant Patients

Alexandre Destere, Aurelie Premaud, Caroline Monchaud, Pierre Marquet, Jean-Baptiste Woillard

Summary: This study aimed to evaluate the relationship between cumulative tacrolimus exposure and the occurrence of new-onset diabetes mellitus (NODM). The study found that tacrolimus concentrations >15 mcg/L increase the risk of NODM.

THERAPEUTIC DRUG MONITORING (2023)

Article Medical Laboratory Technology

Doravirine Exposure Decreased by Dialysis in a HIV Patient: A Grand Round

Yeleen Fromage, Cyrielle Codde, Caroline Monchaud, Marc Labriffe, Minh P. Le, Jean-Francois Faucher, Jean-Baptiste Woillard

Summary: This case report reveals a significant decrease in doravirine concentration due to hemodialysis in a patient with chronic renal failure and HIV-1. Therapeutic drug monitoring is suggested in patients undergoing doravirine treatment with hemodialysis.

THERAPEUTIC DRUG MONITORING (2023)

Article Immunology

Modulation of Monocyte Response by MicroRNA-15b/106a/374a During Antibody-mediated Rejection in Kidney Transplantation

Claire Tinel, Baptiste Lamarthee, Stephane Gazut, Elisabet Van Loon, Florent Von Tokarski, Aurelien Benon, Virginia Sauvaget, Victor Garcia-Paredes, Mickael Menager, Lise Morin, Laila Aouni, Nicolas Cagnard, Marion Rabant, Christophe Legendre, Fabiola Terzi, Marie Essig, Wilfried Gwinner, Maarten Naesens, Pierre Marquet, Dany Anglicheau

Summary: Increasing evidence suggests that microRNAs are involved in the pathophysiology of renal diseases, including kidney transplantation. In this study, the researchers investigated the changes in circulating microRNA expression and their involvement in antibody-mediated rejection. They found that certain microRNAs were significantly decreased in samples with rejection, and these microRNAs were associated with myeloid-related pathways and CD14+ monocytes.

TRANSPLANTATION (2023)

Article Immunology

Can the Area Under the Curve/Trough Level Ratio Be Used to Optimize Tacrolimus Individual Dose Adjustment?

Jean-Baptiste Woillard, Caroline Monchaud, Franck Saint-Marcoux, Marc Labriffe, Pierre Marquet

Summary: This study aimed to evaluate the intraindividual variability of the AUC/C0 ratio in renal transplant recipients and compare it with the variability of AUC, C0, AUC/dose, and C0/dose. The results showed that the AUC/C0 ratio had the lowest relative variation and could be used to calculate individualized C0 targets.

TRANSPLANTATION (2023)

Article Medical Laboratory Technology

Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients

Marc Labriffe, Ludovic Micallef, Jean-Baptiste Woillard, Caroline Monchaud, Franck Saint-Marcoux, Jean Debord, Pierre Marquet

Summary: This study investigates the relationship between mycophenolate mofetil (MMF) doses, mycophenolic acid (MPA) AUC values, and target exposure attainment in pediatric kidney transplant recipients.

THERAPEUTIC DRUG MONITORING (2023)

Article Pharmacology & Pharmacy

A Method for Evaluating Robustness of Limited Sampling Strategies-Exemplified by Serum Iohexol Clearance for Determination of Measured Glomerular Filtration Rate

Markus Hovd, Ida Robertsen, Jean-Baptiste Woillard, Anders Asberg

Summary: Limited sampling strategies (LSS) combined with Bayesian estimates and a population pharmacokinetic model can reduce the number of samples required for individual pharmacokinetic parameter estimations and lighten the burden of assessing AUC in therapeutic drug monitoring. This study evaluated the robustness of parameter estimations in an LSS to deviations from the optimal sample time. The investigated iohexol LSS showed good resilience to deviations in sample time.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Tacrolimus population pharmacokinetics in adult heart transplant patients

Adrien Paschier, Alexandre Destere, Caroline Monchaud, Marc Labriffe, Pierre Marquet, Jean-Baptiste Woillard

Summary: This study developed a population pharmacokinetic (PK) model for tacrolimus in heart transplant patients and built a maximum a posteriori Bayesian estimator (MAP-BE) based on a limited sampling strategy (LSS) to estimate the area under the curve (AUC) and trough concentration (C0). The results showed that the MAP-BE based on LSS had a small bias and imprecision compared to the reference AUC calculated using the trapezoidal rule. The probabilities of target attainment (PTAs) based on AUC or C0 allowed for new recommendations for starting doses in CYP3A5 nonexpressors and expressors.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

Bridging the Worlds of Pharmacometrics and Machine Learning

Kamile Stankeviciute, Jean-Baptiste Woillard, Richard W. Peck, Pierre Marquet, Mihaela van der Schaar

Summary: Precision medicine requires personalized modeling of disease and drug dynamics, and machine learning techniques can provide a solution. However, the complexities in both pharmacology and machine learning pose challenges and require collaboration to achieve synergistic effects.

CLINICAL PHARMACOKINETICS (2023)

Letter Urology & Nephrology

Of End Points and Context of Use: A Reasonable Silver Lining for Urinary Chemokines Monitoring

Angelica Pagliazzi, Elisabet Van Loon, Maarten Naesens

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Multidisciplinary Sciences

High RIPK3 expression is associated with a higher risk of early kidney transplant failure

Adam Wahida, Christoph Schmaderer, Maike Buettner-Herold, Caterina Branca, Sainitin Donakonda, Flora Haberfellner, Carlos Torrez, Jessica Schmitz, Tobias Schulze, Tobias Seibt, Rupert Oellinger, Thomas Engleitner, Bernhard Haller, Katja Steiger, Roman Guenthner, Georg Lorenz, Monica Yabal, Quirin Bachmann, Matthias C. Braunisch, Philipp Moog, Edouard Matevossian, Volker Assfalg, Stefan Thorban, Lutz Renders, Martin R. Spath, Roman-Ulrich Mueller, Dirk L. Stippel, Wilko Weichert, Julia Slotta-Huspenina, Sibylle von Vietinghoff, Ondrej Viklicky, Douglas R. Green, Roland Rad, Kerstin Amann, Andreas Linkermann, Jan Hinrich Brasen, Uwe Heemann, Stephan Kemmner

Summary: Renal ischemia-reperfusion injury is associated with increased risk of graft failure and mortality following renal transplantation. This study identifies high expression of RIPK3 as a potential marker for predicting one-year transplant failure.

ISCIENCE (2023)

Article Infectious Diseases

Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages

S. Jahanbakhsh, J. Howland, M. O. Ndayishimiye Uwineza, M. T. Thwaites, C. M. Pillar, A. W. Serio, D. M. Anastasiou, D. A. Hufnagel

Summary: Omadacycline demonstrated intracellular activity against M. abscessus, similar to tigecycline, but not against clarithromycin and amikacin.

JAC-ANTIMICROBIAL RESISTANCE (2023)

暂无数据